Abstract
The synthesis and characterization of 2,3-dihydro-5,15-di(3,5-dihydroxyphenyl) porphyrin is reported. The phototoxicity on C6 cell lines and the pharmacokinetics are also reported as preliminary results showing a very high tumor to skin ratio and short retention time in tissues, and thus promising activity in photodynamic therapy.
MeSH terms
-
Animals
-
Antineoplastic Agents / chemistry*
-
Antineoplastic Agents / pharmacokinetics
-
Antineoplastic Agents / pharmacology*
-
Drug Screening Assays, Antitumor
-
Humans
-
Mesoporphyrins / pharmacokinetics
-
Mesoporphyrins / pharmacology
-
Mice
-
Neoplasms, Experimental
-
Photochemotherapy / methods
-
Photosensitizing Agents / chemistry*
-
Photosensitizing Agents / pharmacokinetics
-
Photosensitizing Agents / pharmacology*
-
Porphyrins / chemistry*
-
Porphyrins / pharmacokinetics
-
Porphyrins / pharmacology*
-
Rats
-
Reference Standards
-
Skin Neoplasms / drug therapy
-
Spectrometry, Fluorescence
-
Tissue Distribution
-
Tumor Cells, Cultured
Substances
-
Antineoplastic Agents
-
Mesoporphyrins
-
Photosensitizing Agents
-
Porphyrins
-
temoporfin